OSE Immunotherapeutics
OSE.PA
#10411
Rank
A$59.87 M
Marketcap
A$2.34
Share price
-7.17%
Change (1 day)
-76.04%
Change (1 year)

Earnings for OSE Immunotherapeutics (OSE.PA)

Earnings in 2025: -A$66.41 Million

According to OSE Immunotherapeutics's latest financial reports the company's current earnings are A$3.07 Million. In 2025 the company made an earning of -A$66.41 Million a decrease over its 2024 earnings that were of A$62.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OSE Immunotherapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025-A$66.41 Million-206.04%
2024A$62.62 M-261.47%
2023-A$38.79 Million32.79%
2022-A$29.21 Million-0.83%
2021-A$29.46 Million-17.65%
2020-A$35.77 Million1343.42%
2019-A$2.48 Million-130.46%
2018A$8.13 M-135.22%
2017-A$23.1 Million-182.62%
2016A$27.95 M-403.67%
2015-A$9.21 Million76.85%
2014-A$5.21 Million897.97%
2013-A$0.53 Million-81.82%
2012-A$2.87 Million